KLK15 and metabolic dysfunction-associated steatotic liver disease: Previous studies have shown that the transcription factors, SREBP-1c, the PPARα, and the expression of their targeting genes, such as the FAS, ACC, CPT-1, and ACO, are crucial for the development of NAFLD.